BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34881812)

  • 1. Suvorexant with or without ramelteon to prevent delirium: a systematic review and meta-analysis.
    Tian Y; Qin Z; Han Y
    Psychogeriatrics; 2022 Mar; 22(2):259-268. PubMed ID: 34881812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Effectiveness of Ramelteon and Suvorexant for Delirium Prevention in 948 Patients With Delirium Risk Factors.
    Hatta K; Kishi Y; Wada K; Takeuchi T; Hashimoto N; Suda K; Taira T; Tsuchida K; Ohmori T; Akizuki N; Nishio Y; Nakanishi Y; Usui C; Kurata A; Horikawa N; Eguchi H; Ito S; Muto H; Nakamura H; Uchimura N
    J Clin Psychiatry; 2019 Dec; 81(1):. PubMed ID: 31851436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of Suvorexant to Ramelteon Therapy for Improved Sleep Quality with Reduced Delirium Risk in Acute Stroke Patients.
    Kawada K; Ohta T; Tanaka K; Miyamura M; Tanaka S
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):142-148. PubMed ID: 30322756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin and its analogues for the prevention of postoperative delirium: A systematic review and meta-analysis.
    Han Y; Wu J; Qin Z; Fu W; Zhao B; Li X; Wang W; Sha T; Sun M; Li J; Zeng Z; Chen Z
    J Pineal Res; 2020 May; 68(4):e12644. PubMed ID: 32145098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of suvorexant in the prevention of delirium during acute hospitalization: A systematic review.
    Adams AD; Pepin MJ; Brown JN
    J Crit Care; 2020 Oct; 59():1-5. PubMed ID: 32480359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive Effects of Ramelteon, Suvorexant, and Lemborexant on Delirium in Hospitalized Patients With Physical Disease: A Retrospective Cohort Study.
    Henmi R; Nakamura T; Mashimoto M; Takase F; Ozone M
    J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):369-377. PubMed ID: 38820374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association Suvorexant and Ramelteon Use with the Risk of Falling: A Retrospective Case-control Study].
    Ishigo T; Takada R; Kondo F; Ibe Y; Nakano K; Tateishi R; Fujii S; Katano S; Kitagawa M; Kimyo T; Nakata H; Hashimoto A; Miyamoto A
    Yakugaku Zasshi; 2020; 140(8):1041-1049. PubMed ID: 32741862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Use of Ramelteon for Delirium in Hospitalized Patients: A Systematic Review and Meta-Analyses.
    Dang V; Mansukhani MP; Wang Z; Kinzelman Vesely E; Kolla BP
    J Acad Consult Liaison Psychiatry; 2023; 64(1):65-72. PubMed ID: 35718086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suvorexant for the prevention of delirium: A meta-analysis.
    Xu S; Cui Y; Shen J; Wang P
    Medicine (Baltimore); 2020 Jul; 99(30):e21043. PubMed ID: 32791676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of combined use of Suvorexant and Ramelteon in preventing postoperative delirium: a retrospective comparative study.
    Ikeuchi S; Tanaka R; Sugiura T; Shinsato K; Wakabayashi A; Sato J; Suzuki K; Shino M
    J Pharm Health Care Sci; 2023 Dec; 9(1):42. PubMed ID: 38037168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ramelteon for delirium prevention in hospitalized patients: An updated meta-analysis and trial sequential analysis of randomized controlled trials.
    Yu CL; Carvalho AF; Thompson T; Tsai TC; Tseng PT; Tu YK; Yang SN; Yang FC; Chang CH; Hsu CW; Hsu TW; Liang CS
    J Pineal Res; 2023 Apr; 74(3):e12857. PubMed ID: 36726202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative delirium after pharyngolaryngectomy with esophagectomy: a role for ramelteon and suvorexant.
    Booka E; Tsubosa Y; Matsumoto T; Takeuchi M; Kitani T; Nagaoka M; Imai A; Kamijo T; Iida Y; Shimada A; Takebayashi K; Niihara M; Mori K; Onitsuka T; Takeuchi H; Kitagawa Y
    Esophagus; 2017; 14(3):229-234. PubMed ID: 28725169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Hypnotic Drug Use with Fall Incidents in Hospitalized Elderly Patients: A Case-Crossover Study.
    Torii H; Ando M; Tomita H; Kobaru T; Tanaka M; Fujimoto K; Shimizu R; Ikesue H; Okusada S; Hashida T; Kume N
    Biol Pharm Bull; 2020; 43(6):925-931. PubMed ID: 32475914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study.
    Ishibashi Y; Nishitani R; Shimura A; Takeuchi A; Touko M; Kato T; Chiba S; Ashidate K; Ishiwata N; Ichijo T; Sasabe M
    PLoS One; 2020; 15(9):e0238723. PubMed ID: 32916693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suvorexant is associated with a low incidence of delirium in critically ill patients: a retrospective cohort study.
    Masuyama T; Sanui M; Yoshida N; Iizuka Y; Ogi K; Yagihashi S; Nagatomo K; Sasabuchi Y; Lefor AK
    Psychogeriatrics; 2018 May; 18(3):209-215. PubMed ID: 29423967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin Receptor Agonists for the Prevention of Delirium: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Maneeton B; Kongsaengdao S; Maneeton N; Likhitsathian S; Woottiluk P; Kawilapat S; Srisurapanont M
    Curr Neuropharmacol; 2022; 20(10):1956-1968. PubMed ID: 35524672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin and Ramelteon for the treatment of delirium: A systematic review and meta-analysis.
    Beaucage-Charron J; Rinfret J; Coveney R; Williamson D
    J Psychosom Res; 2023 Jul; 170():111345. PubMed ID: 37150157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ramelteon and suvorexant for postoperative delirium in elderly patients with esophageal cancer.
    Mayanagi S; Haneda R; Inoue M; Ishii K; Tsubosa Y
    Esophagus; 2023 Oct; 20(4):635-642. PubMed ID: 37561254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prompt improvement of difficulty with sleep initiation and waking up in the morning and daytime somnolence by combination therapy of suvorexant and ramelteon in delayed sleep-wake phase disorder: a case series of three patients.
    Izuhara M; Kawano K; Otsuki K; Hashioka S; Inagaki M
    Sleep Med; 2021 Apr; 80():100-104. PubMed ID: 33588260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin, Ramelteon, Suvorexant, and Dexmedetomidine to Promote Sleep and Prevent Delirium in Critically Ill Patients: A Narrative Review With Practical Applications.
    Fontaine GV; Der Nigoghossian C; Hamilton LA
    Crit Care Nurs Q; 2020; 43(2):232-250. PubMed ID: 32084065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.